R3VIVE FRANCHISE LLC – Trademark Portfolio

Entity Type: 16

R3VIVE FRANCHISE LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 8 filings in this category. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include R3LIVE, R3VIVE, and RELIVE. The owner is based in STUART, FL.

838 SW FEDERAL HWY

STUART, FL 34994

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RELIVE
RELIVE
Abandoned 2023
RELIVE
RELIVE
Pending 2022
R3LIVE
R3LIVE
Pending 2022
Trademark
Serial #97692128
Registered 2022
RELIVE
RELIVE
Registered 2021
R3LIVE
R3LIVE
Registered 2021
R3VIVE
R3VIVE
Registered 2019

Trademark Classifications

R3VIVE FRANCHISE LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (8 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does R3VIVE FRANCHISE LLC have?

R3VIVE FRANCHISE LLC has 8 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 2 abandoned.

What trademark classes does R3VIVE FRANCHISE LLC file in?

R3VIVE FRANCHISE LLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are R3VIVE FRANCHISE LLC's most well-known trademarks?

R3VIVE FRANCHISE LLC's registered trademark portfolio includes well-known marks such as R3LIVE, R3VIVE, and RELIVE. These are among 4 currently registered trademarks in the portfolio.

What is R3VIVE FRANCHISE LLC's trademark registration success rate?

R3VIVE FRANCHISE LLC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.